SemBioSys Genetics Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Bankr. Admin/​Reorg

SemBioSys Genetics General Information

Description

Developer of biotechnology solutions committed to changing the way pharmaceuticals, nutritional oils and agricultural products are produced. The company focuses in the development stage of agricultural biotechnology that utilizes plant seed-based oil body and genetic expression technology platforms to develop high value proteins and oils and drug candidates in oil seed-producing plant species, thereby providing a cost-effective production solution for drugs needed in large quantities.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 2985-23rd Avenue North East
  • Suite 110
  • Calgary, Alberta T1Y 7L3
  • Canada
+1 (403)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 2985-23rd Avenue North East
  • Suite 110
  • Calgary, Alberta T1Y 7L3
  • Canada
+1 (403)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SemBioSys Genetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Bankruptcy: Admin/Reorg 01-Jan-2012 Completed Generating Revenue
11. PIPE 18-Mar-2011 Completed Generating Revenue
10. PIPE 24-Mar-2010 Completed Generating Revenue
9. PIPE 04-May-2009 Completed Generating Revenue
8. PIPE 20-Dec-2005 Completed Generating Revenue
7. Debt - General 21-Nov-2005 Completed Generating Revenue
6. PIPE 14-Dec-2004 Completed Generating Revenue
5. IPO 06-Dec-2004 Completed Generating Revenue
4. Later Stage VC 30-Apr-2003 $1.72M $17.7M Completed Generating Revenue
3. Later Stage VC 31-Jan-2002 $1.5M $16M Completed Generating Revenue
To view SemBioSys Genetics’s complete valuation and funding history, request access »

SemBioSys Genetics Patents

SemBioSys Genetics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2009234384-A1 Controlled release of active agents from oleosomes Inactive 11-Apr-2008
AU-2009234384-A8 Controlled release of active agents from oleosomes Inactive 11-Apr-2008
CA-2720755-A1 Controlled release of active agents from oleosomes Inactive 11-Apr-2008
EP-2274015-A2 Controlled release of active agents from oleosomes Inactive 11-Apr-2008
US-20110081386-A1 Controlled release of active agents from oleosomes Inactive 11-Apr-2008 A61K9/0014
To view SemBioSys Genetics’s complete patent history, request access »

SemBioSys Genetics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SemBioSys Genetics FAQs

  • When was SemBioSys Genetics founded?

    SemBioSys Genetics was founded in 1994.

  • Where is SemBioSys Genetics headquartered?

    SemBioSys Genetics is headquartered in Calgary, Canada.

  • What is the size of SemBioSys Genetics?

    SemBioSys Genetics has 21 total employees.

  • What industry is SemBioSys Genetics in?

    SemBioSys Genetics’s primary industry is Biotechnology.

  • Is SemBioSys Genetics a private or public company?

    SemBioSys Genetics is a Private company.

  • What is SemBioSys Genetics’s current revenue?

    The current revenue for SemBioSys Genetics is .

  • How much funding has SemBioSys Genetics raised over time?

    SemBioSys Genetics has raised $55.3M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process